Stanford Health Care, Stanford, CA, USA.
Stanford University School of Medicine, Department of Pathology, Stanford, CA, USA.
Sci Rep. 2020 Apr 24;10(1):7001. doi: 10.1038/s41598-020-63882-z.
Human papillomavirus (HPV) types differ by geographic location and the ethnicity of the human host, which may have implications for carcinogenicity. HPV35 is one of the least frequently identified high-risk types in North America and Europe but was the most common high-risk HPV (hrHPV) infection in a cohort in rural Zimbabwe. Whole genome analysis is limited for HPV35; no such studies have been performed in Zimbabwe. Of 648 women in the initial cohort in Zimbabwe, 19 (19/648, 2.9%) tested positive for HPV35, and eight samples were successfully sequenced for HPV35. The maximum number of sequence variants for the whole genome was 58 nucleotides (0.7%) compared to the prototype (58/7879). The maximum number of sequence variants in E6 and E7 was 3 (3/450, 0.7%) 2 (2/300, 0.7%), respectively. These are the first HPV35 whole genome sequences from Zimbabwe, and these data further lend support to the carcinogenicity of HPV35 despite limited sequence heterogeneity. Further studies to determine carcinogenic effects and impact of HPV vaccinations are warranted, especially in sub-Saharan Africa.
人乳头瘤病毒(HPV)类型因地理位置和人类宿主的种族而异,这可能对致癌性有影响。HPV35 是北美和欧洲最不常见的高危型之一,但在津巴布韦农村的一个队列中是最常见的高危 HPV(hrHPV)感染。HPV35 的全基因组分析受到限制;在津巴布韦尚未进行过此类研究。在津巴布韦最初的队列中,有 648 名女性,其中 19 名(19/648,2.9%)HPV35 检测呈阳性,8 个样本成功进行了 HPV35 测序。与原型(58/7879)相比,全基因组的最大序列变异数为 58 个核苷酸(0.7%)。E6 和 E7 的最大序列变异数分别为 3(3/450,0.7%)和 2(2/300,0.7%)。这是津巴布韦首例 HPV35 全基因组序列,这些数据进一步支持 HPV35 的致癌性,尽管其序列异质性有限。需要进一步研究以确定 HPV35 的致癌作用和 HPV 疫苗接种的影响,特别是在撒哈拉以南非洲。